NewGLab Pharma Co Ltd banner
N

NewGLab Pharma Co Ltd
KOSDAQ:214870

Watchlist Manager
NewGLab Pharma Co Ltd
KOSDAQ:214870
Watchlist
Price: 6 915 KRW -27.44%
Market Cap: ₩439.9m

NewGLab Pharma Co Ltd
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

NewGLab Pharma Co Ltd
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
N
NewGLab Pharma Co Ltd
KOSDAQ:214870
Research & Development
-₩271.7m
CAGR 3-Years
71%
CAGR 5-Years
32%
CAGR 10-Years
N/A
Woojin Inc
KRX:105840
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
F
FiberPro Inc
KOSDAQ:368770
Research & Development
-₩1.9B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
R
Robostar Co Ltd
KOSDAQ:090360
Research & Development
-₩1.7B
CAGR 3-Years
18%
CAGR 5-Years
8%
CAGR 10-Years
5%
P
Park Systems Corp
KOSDAQ:140860
Research & Development
-₩16.3B
CAGR 3-Years
-29%
CAGR 5-Years
-18%
CAGR 10-Years
-23%
W
Woori Technology Inc
KOSDAQ:032820
Research & Development
-₩1.1B
CAGR 3-Years
-7%
CAGR 5-Years
5%
CAGR 10-Years
N/A
No Stocks Found

NewGLab Pharma Co Ltd
Glance View

Market Cap
439.9m KRW
Industry
Electrical Equipment

NewGLAB Pharma Co., Ltd. engages in the manufacture of closed-circuit television camera and equipment. The company is headquartered in Bucheon, Gyeonggi-Do. The company went IPO on 2015-10-13. The firm's product portfolio consists of general analog cameras that used for CCTVs, high definition (HD) analog cameras, HD-serial digital interface (SDI) cameras, extend (EX)-SDI cameras, internet protocol (IP) cameras that used for network CCTVs, digital video recorders (DVRs) that used for image storage devices, network video recorders (NVRs) and others. In addition, the Company is involved in the business of 5G smartphone distribution. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
37 305.87 KRW
Undervaluation 81%
Intrinsic Value
Price
N

See Also

What is NewGLab Pharma Co Ltd's Research & Development?
Research & Development
-271.7m KRW

Based on the financial report for Dec 31, 2024, NewGLab Pharma Co Ltd's Research & Development amounts to -271.7m KRW.

What is NewGLab Pharma Co Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
32%

Over the last year, the Research & Development growth was 92%. The average annual Research & Development growth rates for NewGLab Pharma Co Ltd have been 71% over the past three years , 32% over the past five years .

Back to Top